We identified that ATM-associated DNA damage is responsible for SALL1-mediated breast cancer cell senescence, by analyzing activation of ATM and its related targets, as well as using loss-of-function approaches with a specific pharmacological ATM inhibitor and shRNA. Here, SALL1 is linked to breast carcinoma.